ACADIA Pharmaceuticals Inc. vs SkyWest Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.84 (market cap $5.07B), while SkyWest Inc trades at $108.98 (market cap $4.19B). The key difference: ACADIA Pharmaceuticals Inc. is the larger of the two by market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, SkyWest Inc nearer its low. Which is the better fit depends on your goals.
| ACAD | SKYW | |
|---|---|---|
Market Cap | $5.07B | $4.19B |
Sector | Health | Technology |
52-Week High | $29.41 | $123.72 |
52-Week Low | $20.06 | $78.40 |
Enterprise Value | $4.19B | $5.97B |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →SkyWest, Inc. is a major North American regional airline company, operating primarily through its subsidiary, SkyWest Airlines. The company provides regional airline service to various large airlines under contract, including United Airlines (as United Express), Delta Air Lines (as Delta Connection), American Airlines (as American Eagle), and Alaska Airlines (as Alaska SkyWest). SKYW's primary business is providing essential flight services, connecting smaller cities to major airline hubs across the United States.
Read more on SKYW →